Benign Inflammatory Lesion Mimicking Malignancy “Kimura’s Disease”: A Case Report

Putu Erika Paskarani, Luh Ayu Widayanti, Anak Agung Ayu Ngurah Susraini, Herman Saputra, Ni Putu Sriwidyani

Abstract


Introduction: Kimura’s disease (KD) in Indonesia is quite rare. It is a distinct benign reactive process; however, it is usually mimicking malignancy. It usually affects young adults with a peak incidence in three decades, and men are mostly affected compared to women with a 3:1 ratio. KD is a chronic inflammatory disorder characterized by lymphoid hyperplasia, eosinophilia, and associated with soft tissue swelling that usually arises in head and neck regions with regional lymphadenopathy.

Case Presentation: Herein, we report a case in a 55-year-old man from East Indonesia who presented a huge lump on his left head and neck regions. The lump started about 8 years ago. Physical examination found a tumor mass of 20 x 10 cm with indistinct border and multiple lymphadenopathies left coli with the biggest size of 1.3 x 0.7 x 0.5 cm. Peripheral blood examination shows marked eosinophilia. Nasopharyngeal CT scan revealed soft tissue masses and multiple lymphadenopathies suspected of malignancy; however, thorax plain radiology did not show any sign of metastatic process. Histopathological examination shows reactive follicular proliferation, extensive eosinophilia, focal area Folliculolysis, and polykaryocytes of the WarthinFinkeldey type.

Conclusion: Based on a complete history, laboratory findings, and histopathological examination, this case is concluded as Kimura’s disease. Although clinical findings and radiological examination suspected it as malignancy, those discrepancies were confirmed as a benign lesion by specific histopathological and laboratory findings. Commonly, most patients have a favorable prognosis and good response to therapy.


Keywords


eosinophilia, Kimura’s disease, lymphadenopathy

Full Text: View | Download

DOI: 10.33371/ijoc.v14i4.762

Article Metrics

Abstract View: 383,
PDF Download: 400
             

References


Fouda MA, Gheith O, Refaie A, et al. Kimura disease: A case report and review of the literature with a new management protocol. Int J Nephrol. 2011;2010:673908.

Larroche C, Bletry O. Kimura’s disease. Orphaner Encyclopedia. 2005: 1-3.

Luo Y, Sun YJ, Luan XL, et al. Radiation therapy treats recalcitrant Kimura’s disease: a case report. Int J Clin Exp Med. 2017;10(9):13900-5.

Miranda R, Khoury J, Medeiros LJ. Kimura lymphadenopathy. Atlas of lymph node pathology SE—25. New York: Springer. 2013:101–3.

Ioachim HL, Medeirus LJ. Kimura Lymphadenopathy. Ioachim’s Lymph Node Pathology 4th Edition. Philadelphia. 2009:190-192.

Garcia Carratero R, Romero Brugera M, Rebollo-Aparicio N, Vazquez-Gomez O. Eosinophilia and multiple lymphadenopathy: Kimura disease, a rare, but benign condition. BMJ Case Rep. 2016;2016:bcr2015214211.

Swerdlow SH, Campo E, Harris NL, et al. Hodgkin Lymphoma in : Jaff E.S., Stein H., Swerdlow SH. WHO Classification of Tumours of Hematopoetic and Lymphoid Tissues (Revised 4th edition). Lyon: International Agency for Research on Cancer, 2017. P 435-440.

Roberto NM, Joseph BK, Jefrey LM. Kimura Lymphadenopathy. Atlas of Lymph Node Pathology. Springer. 2013

Sherpa M, Lamichaney R, Roy AD. Kimura’s disease: A diagnostic challenge experienced with cytology of postauricular swelling with histopathological relevance. J Cytol. 2016;33:232-5.

Arber DA. Lymph Node. Goldblum J R, Lamps L W, McKneey J K, Myers J R, editors. Rosai and Ackerman’s Surgical Pathology, 11th edition. Philadelphia: Elsevier. 2018: p.1560

Kumar V, Abbas AK, Aster JC. Lymph Nodes, Spleen and Thymus. In. Robbins and Cotran Pathologic Basic of Diseases 9th edition. Philadelphia : Elsevier. 2015:584-5

Hareyama M, Oouchi A, Nagakura H, et al. Radiotherapy for Kimura’s Disease : the optimum dosage. Int J of Radiat Oncol Biol Phys. 1998;40(3):647-51.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Indonesian Journal of Cancer

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.